| Literature DB >> 16404365 |
G Atkin1, F M Daley, S Bourne, R Glynne-Jones, J Northover, G D Wilson.
Abstract
Delays in tissue fixation following tumour vascular clamping and extirpation may adversely affect subsequent protein and mRNA analysis. This study investigated the effect of surgically induced ischaemia in a xenograft model of a colorectal cancer on the expression of a range of prognostic, predictive, and hypoxic markers, with a particular emphasis on thymidylate synthase. Vascular occlusion of human tumour xenografts by D-shaped metal clamps permitted defined periods of tumour ischaemia. Alterations in protein expression were measured by immunohistochemistry and spectral imaging, and changes in mRNA were measured by reverse transcriptase-polymerase chain reaction. Thymidylate synthase expression decreased following vascular occlusion, and this correlated with cyclin A expression. A similar reduction in dihydropyrimidine dehydrogenase was also seen. There were significant changes in the expression of several hypoxic markers, with carbonic anhydrase-9 showing the greatest response. Gene transcriptional levels were also noted to change following tumour clamping. In this xenograft model, surgically induced tumour ischaemia considerably altered the gene expression profiles of several prognostic and hypoxic markers, suggesting that the degree of tumour ischaemia should be minimised prior to tissue fixation.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16404365 PMCID: PMC2361092 DOI: 10.1038/sj.bjc.6602905
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Figure 1D-clamps used to occlude tumour vascular inflow.
Markers studied, and conditions for immunohistochemistry
|
|
|
|
|
|---|---|---|---|
| Thymidylate synthase (TS) | 4 × 4 min microwave in citric acid with 10 min standing | 1/300 | Simon Joel, London, UK |
| Cyclin A | 3 × 4 min microwave in citric acid with 10 min standing | 1/100 | #NCL-CYCLIN A, Novocastra Labs Ltd, UK |
| Dihydropyrimidine dehydrogenase (DPD) | 4 × 4 min microwave in citric acid with 20 min standing | 1/500 | Masakazu Fukushima, Saitama, Japan |
| Epidermal growth factor receptor (EGFR) | 4 × 4 min microwave in citric acid with 20 min standing | 1/20 | #NCL-L-EGFR, Novocastra Labs Ltd, UK |
| Carbonic anhydrase-9 (CA-9) | None | 1/50 | Adrian Harris, Oxford, UK |
| Glucose transporter-1 (GLUT-1) | 3 × 4 min microwave in citric acid with 10 min standing | I/200 | #A3536, DAKO Corporation, USA |
| Hypoxia inducible factor-1 | 4 × 4 min microwave in citric acid with 20 min standing | 1/1000 | #ab463-100, Abcam Ltd, UK |
| Vascular endothelial growth factor (VEGF) | 3 × 4 min microwave in Tris-HCL with 10 min standing | 1/100 | #MS-350-P1, NeoMarkers Inc., USA |
Figure 2Stain intensity (A) and area (B) profiles for hypoxic markers.
Figure 3Stain intensity (A) and area (B) profiles for prognostic markers.
Figure 4Global changes in marker stain intensity (A) and area (B).
Figure 5mRNA expression profiles for TS and HIF-1α (A) and the global changes in their expression (B).